What Is the Most Suitable Agent Combined With Apatinib for Transarterial Chemoembolization Treatment in Advanced Hepatocellular Carcinoma Patients? A Systematic Review and Network... by Fuhai Hui, Chang Xu, Xiangbo Xu, Jiangxia Chen, Hefeng Geng, Chao Yang, Yingshi Zhang

Get full text

Incidence of renal cell carcinoma after solid organ transplantation: a systematic review and meta-analysis by Chang Xu, Hefeng Geng, Yannan Li, Fang Sun, Huiwei Sun, Yingshi Zhang, Qingchun Zhao

Get full text

Which is the best TACE agent for patients with different NLR hepatocellular carcinomas? A systematic review and network meta-analysis by Shuai Wang, Hefeng Geng, Yizhen Li, Ziang Xu, Kaisi Yang, Ling Yang, Fuhai Hui, Yingshi Zhang

Get full text

The ADAM17 inhibitor ZLDI-8 sensitized hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talk by Chang Xu, Xudong Gao, Tianshu Ren, Hefeng Geng, Kaisi Yang, Yaoguang Huang, Weige Zhang, Shanbo Hou, Aigang Song, Yingshi Zhang, Qingchun Zhao

Get full text